A Randomized, Double Blind, Multicenter, Phase 3 Study of Efficacy, Safety, and Tolerability of Brincidofovir vs Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV-Seropositive Kidney Transplant Recipients who Recieved Antilymphocyte Indu